Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations

Satisfactory management of Parkinson’s disease is a challenge that requires a tailored approach for each individual. In the advanced phase of the disease, patients may experience motor complications despite optimized pharmacological therapy. Apomorphine, a short-acting D 1 - and D 2 -like receptor a...

Full description

Saved in:

Bibliographic Details
Published in:	CNS drugs Vol. 33; no. 9; pp. 905 - 918
Main Authors:	Carbone, Federico, Djamshidian, Atbin, Seppi, Klaus, Poewe, Werner
Format:	Journal Article
Language:	English
Published:	Cham Springer International Publishing 01.09.2019 Springer Nature B.V
Subjects:	Ancient civilizations Apomorphine Bioavailability Clinical medicine Clinical trials Dopamine Dopamine D2 receptors Experiments Levodopa Medical research Medicine Medicine & Public Health Metabolism Morphine Movement disorders Nausea Neurodegenerative diseases Neurology Neurosciences Parkinson's disease Pharmacotherapy Psychiatry Psychopharmacology Review Review Article Tremor (Muscular contraction)
ISSN:	1172-7047, 1179-1934, 1179-1934
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!